|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.9 USD | +3.83% |
|
+2.72% | -17.47% |
Checkpoint Therapeutics, Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was USD 0.035 million compared to USD 0.052 million a year ago. Net loss was USD 10.47 million compared to USD 16.85 million a year ago.
Basic loss per share from continuing operations was USD 0.89 compared to USD 1.98 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -17.47% | 6.74Cr | |
| +50.07% | 5.67TCr | |
| -2.93% | 4.1TCr | |
| +38.14% | 3.81TCr | |
| -11.22% | 2.69TCr | |
| +15.10% | 2.56TCr | |
| -22.57% | 1.86TCr | |
| +0.25% | 1.24TCr | |
| +26.81% | 1.2TCr | |
| +22.86% | 1.19TCr |
CHECKPOINT THERAPEUTICS, INC. 
